
南美洲和中美洲 miRNA 测序和检测市场预测至 2027 年 - COVID-19 影响和按产品(文库制备和耗材)、技术(合成测序、纳米孔和离子半导体测序)和最终用户(研究所、学术界和 CRO)
No. of Pages: 110 | Report Code: TIPRE00022199 | Category: Life Sciences
No. of Pages: 110 | Report Code: TIPRE00022199 | Category: Life Sciences
miRNA是一种20-30个核苷酸的小非编码RNA分子,在基因调控中发挥着重要作用。 miRNA 与信使 RNA (mRNA) 部分互补,其主要功能是下调基因表达。自从它们被发现以来,它们已成为重要细胞功能的重要调节者。 miRNA 与病毒感染、自身免疫性疾病和癌变等病理过程相关。
MicroRNA (miRNA) 参与分化过程,它们充当细胞类型识别的标记。 miRNA 与病毒感染、自身免疫性疾病和癌变等病理过程相关。因此,人们正在进行广泛的研究来鉴定新的 miRNA。此外,关于 miRNA 在疾病发展中的作用的新发现使其成为新型治疗方法的关键目标。几种针对癌症和肝炎等疾病的 miRNA 靶向疗法已进入临床阶段。例如,Santaris Pharma 开发了一种名为 Miravirsen 的治疗分子,靶向 miR-122,用于治疗丙型肝炎病毒(HCV)感染;该分子正处于 II 期临床试验中。因此,用于识别诊断和治疗疾病的新分子的基因组研究资金的增加,以及随之而来的 miRNA 应用范围的扩大,正在推动南美洲和中美洲 miRNA 测序和检测市场的增长。
各国正在经历 COVID-19 大流行的严重影响。目前,这些国家正在迅速推进各种临床计划来控制这种疾病。对创新诊断技术的日益高度关注导致测序和基因组检测方法的采用越来越多。 Eurofins 基因组学已向巴西医院捐赠了 100,000 份快速 PCR 检测试剂盒,用于检测 SARS-CoV-2。此外,主要参与者也将重点转向先进仪器和产品的开发,这有助于 COVID-19 的诊断。因此,COVID-19 正在支持南美洲和中美洲 miRNA 测序和检测市场的增长。
南美洲和中美洲 miRNA 测序和检测市场按产品细分为文库制备和耗材。耗材细分市场在 2019 年占据了更大的市场份额,而文库制备细分市场预计在预测期内将实现更高的复合年增长率。
基于技术中南美洲 miRNA 测序和分析市场分为合成测序、纳米孔测序和离子半导体测序。合成测序领域在 2019 年占据了最大的市场份额;然而,纳米孔细分市场预计在 2020 年至 2027 年期间将实现最高的复合年增长率。
根据最终用户,南美洲和中美洲 miRNA 测序和检测市场分为研究机构、学术界和 CRO。研究机构细分市场在 2019 年占据最大市场份额,预计在此期间复合年增长率最高。
p>
与这份关于南美洲和中美洲 miRNA 测序和检测市场的报告由药物研究和制造协会 (PhRMA)、经济合作与发展组织 (OECD) 和美国美国食品和药物管理局 (FDA)。
Strategic insights for South and Central America miRNA Sequencing and Assay involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 6.24 Million |
Market Size by 2027 | US$ 13.84 Million |
Global CAGR (2020 - 2027) | 10.6% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South and Central America miRNA Sequencing and Assay refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America miRNA Sequencing and Assay Market is valued at US$ 6.24 Million in 2019, it is projected to reach US$ 13.84 Million by 2027.
As per our report South and Central America miRNA Sequencing and Assay Market, the market size is valued at US$ 6.24 Million in 2019, projecting it to reach US$ 13.84 Million by 2027. This translates to a CAGR of approximately 10.6% during the forecast period.
The South and Central America miRNA Sequencing and Assay Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America miRNA Sequencing and Assay Market report:
The South and Central America miRNA Sequencing and Assay Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America miRNA Sequencing and Assay Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America miRNA Sequencing and Assay Market value chain can benefit from the information contained in a comprehensive market report.